156 related articles for article (PubMed ID: 24493328)
1. Nucleotide differences of coxsackievirus B3 and chronic myocarditis.
Kishimoto C; Takamatsu N; Ochiai H; Kuribayashi K
Heart Vessels; 2015 Jan; 30(1):126-35. PubMed ID: 24493328
[TBL] [Abstract][Full Text] [Related]
2. Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice.
Takada H; Kishimoto C; Kurokawa M; Hiraoka Y
Exp Clin Cardiol; 2003; 8(2):71-5. PubMed ID: 19641653
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
Kishimoto C; Kurokawa M; Ochiai H
J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
[TBL] [Abstract][Full Text] [Related]
4. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants.
Gómez RM; Cui X; Castagnino CG; Berría MI
Intervirology; 1993; 36(3):153-60. PubMed ID: 8150596
[TBL] [Abstract][Full Text] [Related]
5. An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency mouse.
Kishimoto C; Hiraoka Y; Takamatsu N; Takada H; Kamiya H; Ochiai H
Cardiovasc Res; 2003 Nov; 60(2):397-403. PubMed ID: 14613869
[TBL] [Abstract][Full Text] [Related]
6. Failure of treatment with interleukin-2 receptor-specific monoclonal antibody in acute coxsackievirus B3 myocarditis in mice.
Kishimoto C; Hiraoka Y; Takada H; Kurokawa M; Ochiai H
Heart Vessels; 1997; 12(5):221-8. PubMed ID: 9846807
[TBL] [Abstract][Full Text] [Related]
7. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.
Hufnagel G; Chapman N; Tracy S
Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092
[TBL] [Abstract][Full Text] [Related]
8. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
Kishimoto C; Hiraoka Y; Takada H
Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence.
Kiel RJ; Smith FE; Chason J; Khatib R; Reyes MP
Eur J Epidemiol; 1989 Sep; 5(3):348-50. PubMed ID: 2551723
[TBL] [Abstract][Full Text] [Related]
10. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury.
Chow LH; Beisel KW; McManus BM
Lab Invest; 1992 Jan; 66(1):24-31. PubMed ID: 1309927
[TBL] [Abstract][Full Text] [Related]
11. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
Henke A; Huber S; Stelzner A; Whitton JL
J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
[TBL] [Abstract][Full Text] [Related]
12. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
13. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
14. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
Kishimoto C; Ochiai H; Sasayama S
Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy for prevention of acute coxsackievirus B3 myocarditis in mice.
Kishimoto C; Abelmann WH
Circulation; 1989 Jun; 79(6):1300-8. PubMed ID: 2541943
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
Chow LH; Gauntt CJ; McManus BM
Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
[TBL] [Abstract][Full Text] [Related]
17. Role of MIP-2 in coxsackievirus B3 myocarditis.
Kishimoto C; Kawamata H; Sakai S; Shinohara H; Ochiai H
J Mol Cell Cardiol; 2000 Apr; 32(4):631-8. PubMed ID: 10756119
[TBL] [Abstract][Full Text] [Related]
18. Treatment of coxsackievirus B3 myocarditis by immunoactive peptide in an animal model.
Sato Y; Matsumori A
Clin Immunol Immunopathol; 1992 Oct; 65(1):65-9. PubMed ID: 1395125
[TBL] [Abstract][Full Text] [Related]
19. Enteroviral and immune mediated myocarditis in SCID mice.
Schwimmbeck PL; Rohn G; Wrusch A; Schulze K; Doerner A; Kuehl U; Tschoepe C; Pauschinger M; Schultheiss HP
Herz; 2000 May; 25(3):240-4. PubMed ID: 10904845
[TBL] [Abstract][Full Text] [Related]
20. Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction.
Okada I; Matsumori A; Kyu B
Int J Exp Pathol; 1992 Dec; 73(6):721-31. PubMed ID: 1337265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
